---
figid: PMC6244639__395_2018_711_Fig1_HTML
figtitle: Pathomechanisms and clinical features of diabetic cardiomyopathy
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6244639
filename: 395_2018_711_Fig1_HTML.jpg
figlink: /pmc/articles/PMC6244639/figure/Fig1/
number: F1
caption: Pathomechanisms and clinical features of diabetic cardiomyopathy. ↑ increased/↓
  decreased relative to normal conditions; AGE, advanced glycation end products; AT1R,
  angiotensin II receptor type 1; ER, endoplasmic reticulum; FAO, fatty acid (FA)
  oxidation; FAT/CD36, fatty acid translocase; GLOX, glucose oxidation; HBP, hexosamine
  biosynthetic pathway; IR, insulin receptor; PDH, pyruvate dehydrogenase; PDK4, pyruvate
  dehydrogenase kinase 4; PPARα, peroxisome proliferator activated receptor α; PTM,
  posttranslational modification; RAAS, renin–angiotensin–aldosterone system; RAGE,
  receptor for advanced glycation end products; ROS, reactive oxygen species; TF,
  transcription factor; UDP-GlcNAc, uridine diphosphate-N-acetylglucosamine; β2AR,
  β2-adrenergic receptor
papertitle: 'Of mice and men: models and mechanisms of diabetic cardiomyopathy.'
reftext: Christian Riehle, et al. Basic Res Cardiol. 2019;114(1):2.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9587189
figid_alias: PMC6244639__F1
figtype: Figure
redirect_from: /figures/PMC6244639__F1
ndex: 8ea2eb70-deda-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6244639__395_2018_711_Fig1_HTML.html
  '@type': Dataset
  description: Pathomechanisms and clinical features of diabetic cardiomyopathy. ↑
    increased/↓ decreased relative to normal conditions; AGE, advanced glycation end
    products; AT1R, angiotensin II receptor type 1; ER, endoplasmic reticulum; FAO,
    fatty acid (FA) oxidation; FAT/CD36, fatty acid translocase; GLOX, glucose oxidation;
    HBP, hexosamine biosynthetic pathway; IR, insulin receptor; PDH, pyruvate dehydrogenase;
    PDK4, pyruvate dehydrogenase kinase 4; PPARα, peroxisome proliferator activated
    receptor α; PTM, posttranslational modification; RAAS, renin–angiotensin–aldosterone
    system; RAGE, receptor for advanced glycation end products; ROS, reactive oxygen
    species; TF, transcription factor; UDP-GlcNAc, uridine diphosphate-N-acetylglucosamine;
    β2AR, β2-adrenergic receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - phm
  - bw
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - tf
  - cg
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Glut1
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
  - AGTR1
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - OGT
  - TF
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - SLC2A1
  - SLC2A4
  - AGER
  - MOK
  - Glucose
  - UDP
  - Ceramide
  - O
  - O-GlcNAC
  - DIABETES
  - Mitochondrial dysfunction
  - Fibrosis
  - hypertrophy
  - DIABETIC
---
